Strategic CRO Transition for Enhanced Outcomes in Osteoarthritis Knee Pain

This case study explores how a biotech company successfully transitioned from an underperforming CRO to Worldwide Clinical Trials for their osteoarthritis knee pain study. Faced with slow recruitment and staffing issues, the sponsor recognized the need for a dedicated and agile team. Worldwide's expertise led to a rapid transition, doubling enrollment rates and significantly reducing screen failure rates, demonstrating the importance of strategic CRO partnerships in clinical trials.